1. Home
  2. UCTT vs COLL Comparison

UCTT vs COLL Comparison

Compare UCTT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UCTT
  • COLL
  • Stock Information
  • Founded
  • UCTT 1991
  • COLL 2002
  • Country
  • UCTT United States
  • COLL United States
  • Employees
  • UCTT N/A
  • COLL N/A
  • Industry
  • UCTT Semiconductors
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • UCTT Technology
  • COLL Health Care
  • Exchange
  • UCTT Nasdaq
  • COLL Nasdaq
  • Market Cap
  • UCTT 1.1B
  • COLL 958.8M
  • IPO Year
  • UCTT 2004
  • COLL 2015
  • Fundamental
  • Price
  • UCTT $26.11
  • COLL $36.46
  • Analyst Decision
  • UCTT Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • UCTT 3
  • COLL 4
  • Target Price
  • UCTT $39.00
  • COLL $44.25
  • AVG Volume (30 Days)
  • UCTT 298.7K
  • COLL 447.6K
  • Earning Date
  • UCTT 10-27-2025
  • COLL 11-06-2025
  • Dividend Yield
  • UCTT N/A
  • COLL N/A
  • EPS Growth
  • UCTT N/A
  • COLL N/A
  • EPS
  • UCTT N/A
  • COLL 1.06
  • Revenue
  • UCTT $2,141,100,000.00
  • COLL $707,007,000.00
  • Revenue This Year
  • UCTT N/A
  • COLL $22.23
  • Revenue Next Year
  • UCTT $4.45
  • COLL $2.78
  • P/E Ratio
  • UCTT N/A
  • COLL $32.98
  • Revenue Growth
  • UCTT 14.28
  • COLL 22.61
  • 52 Week Low
  • UCTT $16.66
  • COLL $23.23
  • 52 Week High
  • UCTT $41.90
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • UCTT 53.35
  • COLL 47.68
  • Support Level
  • UCTT N/A
  • COLL $34.71
  • Resistance Level
  • UCTT $25.89
  • COLL $39.12
  • Average True Range (ATR)
  • UCTT 0.79
  • COLL 1.19
  • MACD
  • UCTT -0.74
  • COLL -0.58
  • Stochastic Oscillator
  • UCTT 98.88
  • COLL 33.23

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: